Peptides

AMY1A is a tryptic peptide derived from the alpha-amylase 1 from the salivary gland of the fruit fly, Drosophila melanogaster. Alpha-amylase 1 is a member of the amylase family and has been shown to be biologically active in vitro. AMY1A is used as a calibrator for mass spectrometry and proteomics applications. It is also used in conjunction with other peptides to identify proteins in proteomic experiments.

A synthetic peptide for use as a blocking control in assays to test for specificity of GCK antibody, catalog no. 70R-10324

A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC2 antibody, catalog no. 70R-3937

Peptide Ac-ASGVAVSDGVIK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.

A synthetic peptide for use as a blocking control in assays to test for specificity of CST8 antibody, catalog no. 70R-3907

Peptide IDO199-207 (HLA-A*02:01) is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.

Blocker of tetrodotoxin-sensivite channels

A synthetic peptide for use as a blocking control in assays to test for specificity of ACVR1C antibody, catalog no. 70R-7481

Myoglobin
Myoglobin 137-148 MHC II DRB1*03:01 is a short part of Myoglobin. Myoglobin is protein which binds oxygen or also iron in the skeletal muscle tissue.
Myoglobin 137-148 MHC II DRB1*03:01
Myoglobin 137-148 MHC II DRB1*03:01 is a classical peptide reference for the binding avec MHC II DRB1*03:01. Myoglobin 137-148 is often used to be in competition for study of the relative binding affinity.

A synthetic peptide for use as a blocking control in assays to test for specificity of INTS12 antibody, catalog no. 70R-9072

Biotin-Ova (323-339) is the N-ter biotinylated version of Ova (323-339). Biotin-Ova (323-339) can be used in the analysis of antigen-specific T cells. Ovalbumin protein:
Ova (323-339) is an epitope of interest of the egg white albumen, which is widely used in allergy research. Ovalbumin is a glycoprotein that is sufficiently large and complex to be mildly immunogenic. Indeed, it has been demonstrated that Ovalbumin contains B-cell epitopes which are recognized by specific IgE antibodies and CD4 T cell epitopes restricted by the MHC I-Ad molecule in mice and by HLA-D molecule in human.
Applications of Ova (323-339):
Ova (323-339) allows to study bindings of class II MHC-peptide and T-cell activation in PBMCs by ELISPOT assays. In fact, this method quantifies peptide epitope specificity and IFN-γ releasing effector cells. It has been shown that Ova (323-339) was responsible for 25-35% of T-cell response of isolated BALB/c mouse. An investigation has demonstrated that Ova and Ova (323-339) induced similar lung inflammation and a Th2-like dominant immune response in mouse model.
Sequence: Biotin-ISQAVHAAHAEINEAGR

A synthetic peptide for use as a blocking control in assays to test for specificity of RHOT1 antibody, catalog no. 70R-5953

A synthetic peptide for use as a blocking control in assays to test for specificity of UST antibody, catalog no. 70R-6963

A synthetic peptide for use as a blocking control in assays to test for specificity of AHCY antibody, catalog no. 70R-2721

A synthetic peptide for use as a blocking control in assays to test for specificity of C1QA antibody, catalog no. 70R-9974

A synthetic peptide for use as a blocking control in assays to test for specificity of DLAT antibody, catalog no. 70R-2503

A synthetic peptide for use as a blocking control in assays to test for specificity of PARP10 antibody, catalog no. 70R-8550

Secondary SIL peptide for Emicizumab  detection and quantification

Antagonization of αVβ3 integrin. Inhibition of cell proliferation, migration, invasion, and adhesion of αVβ3 expressing cells.

A synthetic peptide for use as a blocking control in assays to test for specificity of FER1L3 antibody, catalog no. 70R-6290

A synthetic peptide for use as a blocking control in assays to test for specificity of RCAN2 antibody, catalog no. 70R-9145

A synthetic peptide for use as a blocking control in assays to test for specificity of RWDD4A antibody, catalog no. 70R-3398

H-GRCRGFRRRCFCTTHC-OH is a custom research peptide; min purity 95%, TFA salt. For different specs please use the Peptide Quote Tool

A synthetic peptide for use as a blocking control in assays to test for specificity of EARS2 antibody, catalog no. 70R-3329

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC25A33 antibody, catalog no. 70R-10096

Biotin-MAGE-A2 (157-166) is the N-ter biotinylated version of MAGE-A2 (157-166). Biotin-MAGE-A2 (157-166) can be used in the analysis of antigen-specific T cells. MAGE-A2 protein:
MAGE-A2 (157-166) is an epitope of Melanoma Antigen Gene A2 and is one of the most Cancer-Testis Antigens (CTA) overexpressed in tumors of different histological types, such as prostate cancer. Type of MAGE-A expressed in tumors cells varies according to the type of tumor. The expression of MAGE-A2 causes the proliferation of prostate cancer cells and decreases the chemosensitivity.
Applications of MAGE-A2 (157-166):
MAGE-A2 (157-166) is used to stimulate specific immune response, cytotoxic T cell response and to analyze the cytokine production in PBMCs by ELISPOT assay. In transgenic mouse, it has been demonstrated that MAGE-A2 (157-166) was capable of eliciting a CTL response presented by HLA-A*02:01 molecules. MAGE-A2 (157-166) has been reported to elicit CTL that could lyse tumor cell expressing both HLA-A*02:01 and MAGE-A2 by stimulation of peripheral blood mononuclear cells (PBMCs) with MAGE-A2 (157-166).
Sequence: Biotin-YLQLVFGIEV

A synthetic peptide for use as a blocking control in assays to test for specificity of PGS1 antibody, catalog no. 70R-5274

A synthetic peptide for use as a blocking control in assays to test for specificity of MAP3K14 antibody, catalog no. 70R-3485

A synthetic peptide for use as a blocking control in assays to test for specificity of TGOLN2 antibody, catalog no. 70R-7394

Selective blocker of SK2 (KCa2.2) channels

A synthetic peptide for use as a blocking control in assays to test for specificity of SPATA17 antibody, catalog no. 70R-3187

A synthetic peptide for use as a blocking control in assays to test for specificity of PNMA2 antibody, catalog no. 70R-9173

A synthetic peptide for use as a blocking control in assays to test for specificity of BRPF3 antibody, catalog no. 70R-8944

A synthetic peptide for use as a blocking control in assays to test for specificity of QARS antibody, catalog no. 70R-9414

A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf64 antibody, catalog no. 70R-10061

A synthetic peptide for use as a blocking control in assays to test for specificity of ACSS2 antibody, catalog no. 70R-10248

SARS-CoV-2 Spike RBD 371-394 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). SARS-CoV-2 Spike RBD 371-394 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.
SB-PEPTIDE also offers SARS-CoV-2 Spike RBD 371-394 (Biotin-LC) peptide

A synthetic peptide for use as a blocking control in assays to test for specificity of PDK1 antibody, catalog no. 70R-5750

A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC49 antibody, catalog no. 70R-3414

A synthetic peptide for use as a blocking control in assays to test for specificity of ANKRD39 antibody, catalog no. 70R-9456

Biotin-SARS-CoV-2 Spike RBD 513-520 peptide is the biotinylated version of SARS-CoV-2 Spike RBD 513-520 peptide. SARS-CoV-2 Spike RBD 513-520 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). Biotin-SARS-CoV-2 Spike RBD 513-520 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.

A synthetic peptide for use as a blocking control in assays to test for specificity of LST-3TM12 antibody, catalog no. 70R-6339

A synthetic peptide for use as a blocking control in assays to test for specificity of SSX6 antibody, catalog no. 70R-8150

A synthetic peptide for use as a blocking control in assays to test for specificity of TUSC4 antibody, catalog no. 70R-8928

Blocker of Nav1.7 channel

A synthetic peptide for use as a blocking control in assays to test for specificity of GABRR2 antibody, catalog no. 70R-5209